FDA issues azithromycin alert

+News

FDA issues azithromycin alert

FDA sign
The US FDA is advising healthcare professionals not to prescribe long-term azithromycin for prophylaxis of bronchiolitis obliterans syndrome to patients who undergo donor stem cell transplants because of increased potential for cancer relapse and death
Medsafe is aware of a US warning that the antibiotic azithromycin can be harmful to blood and lymph node cancer patients who have undergone stem ce